Exact Mass: 268.0644

Exact Mass Matches: 268.0644

Found 309 metabolites which its exact mass value is equals to given mass value 268.0644, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Formononetin

7-hydroxy-3-(4-methoxyphenyl)-4H-chromen-4-one

C16H12O4 (268.0736)


Formononetin is a member of the class of 7-hydroxyisoflavones that is 7-hydroxyisoflavone substituted by a methoxy group at position 4. It has a role as a phytoestrogen and a plant metabolite. It is a member of 7-hydroxyisoflavones and a member of 4-methoxyisoflavones. It is functionally related to a daidzein. It is a conjugate acid of a formononetin(1-). Formononetin is under investigation in clinical trial NCT02174666 (Isoflavone Treatment for Postmenopausal Osteopenia.). Formononetin is a natural product found in Pterocarpus indicus, Ardisia paniculata, and other organisms with data available. See also: Astragalus propinquus root (part of); Trifolium pratense flower (part of). Formononetin are abundant in vegetables. It is a phyto-oestrogen that is a polyphenolic non-steroidal plant compound with oestrogen-like biological activity (PMID: 16108819). It can be the source of considerable estrogenic activity (http://www.herbalchem.net/Intermediate.htm). Widespread isoflavone found in soy beans (Glycine max), red clover (Trifolium pratense and chick peas (Cicer arietinum). Potential nutriceutical A member of the class of 7-hydroxyisoflavones that is 7-hydroxyisoflavone substituted by a methoxy group at position 4. D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D004967 - Estrogens CONFIDENCE standard compound; INTERNAL_ID 301; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8803; ORIGINAL_PRECURSOR_SCAN_NO 8802 CONFIDENCE standard compound; INTERNAL_ID 301; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8826; ORIGINAL_PRECURSOR_SCAN_NO 8825 CONFIDENCE standard compound; INTERNAL_ID 301; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4484; ORIGINAL_PRECURSOR_SCAN_NO 4480 CONFIDENCE standard compound; INTERNAL_ID 301; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4474; ORIGINAL_PRECURSOR_SCAN_NO 4471 DATA_PROCESSING MERGING RMBmix ver. 0.2.7; CONFIDENCE standard compound; INTERNAL_ID 301; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4474; ORIGINAL_PRECURSOR_SCAN_NO 4470 CONFIDENCE standard compound; INTERNAL_ID 301; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8863; ORIGINAL_PRECURSOR_SCAN_NO 8861 CONFIDENCE standard compound; INTERNAL_ID 301; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4474; ORIGINAL_PRECURSOR_SCAN_NO 4470 CONFIDENCE standard compound; INTERNAL_ID 301; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8847; ORIGINAL_PRECURSOR_SCAN_NO 8844 CONFIDENCE standard compound; INTERNAL_ID 301; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8852; ORIGINAL_PRECURSOR_SCAN_NO 8851 CONFIDENCE standard compound; INTERNAL_ID 301; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8822; ORIGINAL_PRECURSOR_SCAN_NO 8821 CONFIDENCE standard compound; INTERNAL_ID 301; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4569; ORIGINAL_PRECURSOR_SCAN_NO 4566 CONFIDENCE standard compound; INTERNAL_ID 301; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4507; ORIGINAL_PRECURSOR_SCAN_NO 4504 Acquisition and generation of the data is financially supported in part by CREST/JST. INTERNAL_ID 2291; CONFIDENCE Reference Standard (Level 1) CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 2291 IPB_RECORD: 481; CONFIDENCE confident structure Formononetin is a potent FGFR2 inhibitor with an IC50 of ~4.31 μM. Formononetin potently inhibits angiogenesis and tumor growth[1]. Formononetin is a potent FGFR2 inhibitor with an IC50 of ~4.31 μM. Formononetin potently inhibits angiogenesis and tumor growth[1].

   

DL-Homocystine

2-amino-4-[(3-amino-3-carboxypropyl)disulfanyl]butanoic acid

C8H16N2O4S2 (268.0551)


Homocystine is the oxidized form of homocysteine. Homocystine is a dipeptide consisting of two homocysteine molecules joined by a disulfide bond. Homocysteine is a sulfur-containing amino acid that arises during methionine metabolism. Homocystine occurs only transiently before being reduced to homocysteine and converted to the harmless cystathionine via a vitamin B6-dependent enzyme. Homocystine and homocysteine-cysteine mixed disulfides account for >98\\\\\% of total homocysteine in plasma from healthy individuals (PMID 11592966). Homocystine has been shown to stereospecifically induce endothelial nitric oxide synthase-dependent lipid peroxidation in endothelial cells, thereby inducing a vascular cell type-specific oxidative stress. This vascular stress is associated with atherothrombotic cardiovascular disease (PMID: 14980706). High levels of homocysteine (and homocysteine) can be found in individuals suffering from homocystinura due to cystathionine synthase deficiency (PMID: 4685596) Homocystine is the double-bonded form of homocysteine, but it occurs only transiently before being converted to the harmless cystathionine via a vitamin B6-dependent enzyme. Acquisition and generation of the data is financially supported in part by CREST/JST. KEIO_ID H041 4,4'-Disulfanediylbis(2-aminobutanoic acid) is an endogenous metabolite. DL-Homocystine is the double-bonded form of homocysteine and homocysteine is recognized as an important substance in the pathogenesis and pathophysiology of schizophrenia. L-Homocystine is the oxidized member of the L-homocysteine. Homocysteine is a pro-thrombotic factor, vasodilation impairing agent, pro-inflammatory factor and endoplasmatic reticulum-stress inducer used to study cardiovascular disease mechanisms.

   

Tectochrysin

4H-1-Benzopyran-4-one, 5-hydroxy-7-methoxy-2-phenyl- (9CI)

C16H12O4 (268.0736)


7-methylchrysin, also known as 5-hydroxy-7-methoxyflavone or techtochrysin, is a member of the class of compounds known as 7-o-methylated flavonoids. 7-o-methylated flavonoids are flavonoids with methoxy groups attached to the C7 atom of the flavonoid backbone. Thus, 7-methylchrysin is considered to be a flavonoid lipid molecule. 7-methylchrysin is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). 7-methylchrysin can be found in pine nut, prunus (cherry, plum), sour cherry, and sweet cherry, which makes 7-methylchrysin a potential biomarker for the consumption of these food products. relative retention time with respect to 9-anthracene Carboxylic Acid is 1.330 relative retention time with respect to 9-anthracene Carboxylic Acid is 1.324 Tectochrysin (Techtochrysin) is one of the major flavonoids of Alpinia oxyphylla Miquel. Tectochrysin inhibits activity of NF-κB. Tectochrysin (Techtochrysin) is one of the major flavonoids of Alpinia oxyphylla Miquel. Tectochrysin inhibits activity of NF-κB.

   

Dalbergin

6-hydroxy-7-methoxy-4-phenyl-2H-chromen-2-one

C16H12O4 (268.0736)


A polyphenol metabolite detected in biological fluids [PhenolExplorer]

   

Glycine-betaxanthin

(2S,4E)-4-[(2Z)-2-[(carboxymethyl)imino]ethylidene]-1,2,3,4-tetrahydropyridine-2,6-dicarboxylic acid

C11H12N2O6 (268.0695)


   

Isoformononetin

3-(4-Hydroxyphenyl)-7-methoxy-4H-chromen-4-one

C16H12O4 (268.0736)


Isoformononetin is found in pulses. Isoformononetin is isolated from soybean (Glycine max) and other plants. Isolated from soybean (Glycine max) and other plants. Isoformononetin is found in soy bean and pulses. Isoformononetin is an analog of Daidzein (HY-N0019) and has immunoprotective effects. Isoformononetin inhibits the differentiation of Th17 and B-cells lymphopoesis to promote osteogenesis in estrogen-deficient bone loss conditions[1]. Isoformononetin is an analog of Daidzein (HY-N0019) and has immunoprotective effects. Isoformononetin inhibits the differentiation of Th17 and B-cells lymphopoesis to promote osteogenesis in estrogen-deficient bone loss conditions[1].

   

UNII-YJP146PXQT

1-(6-Hydroxy-2-(4-hydroxyphenyl)-1-benzofuran-3-yl)ethanone

C16H12O4 (268.0736)


   

6-Hydroxy-2-methoxyflavone

6-Hydroxy-2-(2-methoxyphenyl)-4H-1-benzopyran-4-one

C16H12O4 (268.0736)


   

DL-Homocystine

4,4-Dithiobis[2-aminobutyric Acid]

C8H16N2O4S2 (268.0551)


4,4'-Disulfanediylbis(2-aminobutanoic acid) is an endogenous metabolite. DL-Homocystine is the double-bonded form of homocysteine and homocysteine is recognized as an important substance in the pathogenesis and pathophysiology of schizophrenia.

   

5-Hydroxy-7-methoxyisoflavone

5-Hydroxy-7-methoxyisoflavone

C16H12O4 (268.0736)


   

8-Hydroxy-1-methoxy-3-methylanthraquinone

8-hydroxy-1-methoxy-3-methyl-9,10-dihydroanthracene-9,10-dione

C16H12O4 (268.0736)


8-Hydroxy-1-methoxy-3-methylanthraquinone is found in garden rhubarb. 8-Hydroxy-1-methoxy-3-methylanthraquinone is a constituent of Rumex acetosa (sorrel). Constituent of Rumex acetosa (sorrel). 8-Hydroxy-1-methoxy-3-methylanthraquinone is found in green vegetables and garden rhubarb.

   

Trigraecum

7-hydroxy-6-methoxy-2-phenyl-4H-chromen-4-one

C16H12O4 (268.0736)


Trigraecum is found in herbs and spices. Trigraecum is isolated from Trigonella foenum-graecum (fenugreek

   

1,3-Dimethoxyanthraquinone

1,3-dimethoxy-9,10-dihydroanthracene-9,10-dione

C16H12O4 (268.0736)


1,3-Dimethoxyanthraquinone is found in beverages. 1,3-Dimethoxyanthraquinone is isolated from Asperula odorata (sweet woodruff). Isolated from Asperula odorata (sweet woodruff). 1,3-Dimethoxyanthraquinone is found in tea, herbs and spices, and beverages.

   

3-(3-hydroxyphenyl)-7-methoxy-4H-chromen-4-one

3-(3-hydroxyphenyl)-7-methoxy-4H-chromen-4-one

C16H12O4 (268.0736)


   

7-Hydroxy-5-methoxy-2-phenyl-chromen-4-one

7-Hydroxy-5-methoxy-2-phenyl-chromen-4-one

C16H12O4 (268.0736)


   

5-Hydroxy-6-methoxyflavone

5-Hydroxy-6-methoxyflavone

C16H12O4 (268.0736)


   

L-Homocystine

2-Amino-4-{[(3S)-3-amino-3-carboxypropyl]disulphanyl}butanoic acid

C8H16N2O4S2 (268.0551)


Homocystine is the oxidized form of homocysteine. Homocystine is a dipeptide consisting of two homocysteine molecules joined by a disulfide bond. Homocysteine is a sulfur-containing amino acid that arises during methionine metabolism. Homocystine occurs only transiently before being reduced to homocysteine and converted to the harmless cystathionine via a vitamin B6-dependent enzyme. Homocystine and homocysteine-cysteine mixed disulfides account for >98\\\% of total homocysteine in plasma from healthy individuals (PMID 11592966). Homocystine has been shown to stereospecifically induce endothelial nitric oxide synthase-dependent lipid peroxidation in endothelial cells, thereby inducing a vascular cell type-specific oxidative stress. This vascular stress is associated with atherothrombotic cardiovascular disease (PMID: 14980706). High levels of homocysteine (and homocysteine) can be found in individuals suffering from homocystinura due to cystathionine synthase deficiency (PMID: 4685596) Homocystine is the double-bonded form of homocysteine, but it occurs only transiently before being converted to the harmless cystathionine via a vitamin B6-dependent enzyme. L-Homocystine is the oxidized member of the L-homocysteine. Homocysteine is a pro-thrombotic factor, vasodilation impairing agent, pro-inflammatory factor and endoplasmatic reticulum-stress inducer used to study cardiovascular disease mechanisms.

   

Homolanthionine

2-Amino-4-(3-amino-3-carboxypropanesulphonyl)butanoic acid

C8H16N2O6S (268.0729)


Homolanthionine is formed from homocysteine and homoserine by a condensation analogous to that normally leading to cystathionine. The only other known occurrence of homolanthionine in nature is in a methionine-requiring mutant strain of Escherichia coli. Patients with homocystinuria excrete small amounts of L-homolanthionine in their urine. [HMDB] Homolanthionine is formed from homocysteine and homoserine by a condensation analogous to that normally leading to cystathionine. The only other known occurrence of homolanthionine in nature is in a methionine-requiring mutant strain of Escherichia coli. Patients with homocystinuria excrete small amounts of L-homolanthionine in their urine.

   

DHAP(6:0)

[3-(hexanoyloxy)-2-oxopropoxy]phosphonic acid

C9H17O7P (268.0712)


DHAP(6:0) is the hexanoyl derivative of Dihydroxyacetone phosphate. It is also known as an alkyl-DHAP. This compound is formed by hexanoic acid reacting with DHAP. Alkyl-DHAPs are intermediates in the synthesis of ether phospholipids. The initial steps of ether phospholipid biosynthesis take place in peroxisomes. Alkyl-dihydroxyacetonephosphate synthase is the peroxisomal enzyme that actually introduces the ether linkage. Levels of Alkyl-DHAP have been found to be strongly reduced in human fibroblasts derived from Zellweger syndrome and rhizomelic chondrodysplasia punctata patients. Four other enzymes are known to be involved in the metabolism of acyl-DHAP and alkyl-DHAP. These include: acyl-DHAP/alkyl-DHAP oxidoreductase, DHAP acyltransferase, alkyl-DHAP phosphohydrolase, and a dinitrofluorobenzene-insensitive acyl-DHAP acylhydrolase. Dihydroxyacetone phosphate (DHAP) is a biochemical compound primarily involved in the glycolysis metabolic pathway. DHAP is also the product of the dehydrogenation of L-glycerol-3-phosphate which is part of the entry of glycerol (sourced from triglycerides) into the glycolytic pathway. Conversely, reduction of glycolysis-derived DHAP to L-glycerol-3-phosphate provides adipose cells with the activated glycerol backbone they require to synthesize new triglycerides. Both reactions are catalyzed by the enzyme glycerol 3-phosphate dehydrogenase with NAD+/NADH as cofactor. DHAP may be referred to as glycerone phosphate in older texts. [HMDB] DHAP(6:0) is the hexanoyl derivative of Dihydroxyacetone phosphate. It is also known as an alkyl-DHAP. This compound is formed by hexanoic acid reacting with DHAP. Alkyl-DHAPs are intermediates in the synthesis of ether phospholipids. The initial steps of ether phospholipid biosynthesis take place in peroxisomes. Alkyl-dihydroxyacetonephosphate synthase is the peroxisomal enzyme that actually introduces the ether linkage. Levels of Alkyl-DHAP have been found to be strongly reduced in human fibroblasts derived from Zellweger syndrome and rhizomelic chondrodysplasia punctata patients. Four other enzymes are known to be involved in the metabolism of acyl-DHAP and alkyl-DHAP. These include: acyl-DHAP/alkyl-DHAP oxidoreductase, DHAP acyltransferase, alkyl-DHAP phosphohydrolase, and a dinitrofluorobenzene-insensitive acyl-DHAP acylhydrolase. Dihydroxyacetone phosphate (DHAP) is a biochemical compound primarily involved in the glycolysis metabolic pathway. DHAP is also the product of the dehydrogenation of L-glycerol-3-phosphate which is part of the entry of glycerol (sourced from triglycerides) into the glycolytic pathway. Conversely, reduction of glycolysis-derived DHAP to L-glycerol-3-phosphate provides adipose cells with the activated glycerol backbone they require to synthesize new triglycerides. Both reactions are catalyzed by the enzyme glycerol 3-phosphate dehydrogenase with NAD+/NADH as cofactor. DHAP may be referred to as glycerone phosphate in older texts.

   

(1S,2R)-N-Methyl-1-oxo-2-pyridin-3-ylthiane-2-carbothioamide

N-methyl-1-oxo-2-(pyridin-3-yl)-1lambda4-thiane-2-carbothioamide

C12H16N2OS2 (268.0704)


   

8-Methylxanthen-9-one-4-acetic acid

2-(8-methyl-9-oxo-9H-xanthen-4-yl)acetic acid

C16H12O4 (268.0736)


   

5,5-Diphenyl-2-thiohydantoin

5,5-diphenyl-2-sulfanylideneimidazolidin-4-one

C15H12N2OS (268.067)


   

Alconil

Spiro(2-fluoro-9H-fluorene-9,4-imidazolidine)-2,5-dione

C15H9FN2O2 (268.0648)


   

Dimethyl cystine

methyl 2-amino-3-[(2-amino-3-methoxy-3-oxopropyl)disulfanyl]propanoate

C8H16N2O4S2 (268.0551)


   

Ethylenedicysteine

2-({2-[(1-carboxy-2-sulfanylethyl)amino]ethyl}amino)-3-sulfanylpropanoic acid

C8H16N2O4S2 (268.0551)


   

Furobufen

4-{8-oxatricyclo[7.4.0.0²,⁷]trideca-1(13),2,4,6,9,11-hexaen-4-yl}-4-oxobutanoic acid

C16H12O4 (268.0736)


C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic

   

Pyran-3,4-dicarboxylic anhydride, tetrahydro-2-methyl-6-(tetrahydro-2,5-dioxo-3-furyl)-, polymer

Pyran-3,4-dicarboxylic anhydride, tetrahydro-2-methyl-6-(tetrahydro-2,5-dioxo-3-furyl)-, polymer

C12H12O7 (268.0583)


   

Penicillamine cysteine disulfide

2-Amino-3-[(2-amino-2-carboxyethyl)disulphanyl]-3-methylbutanoic acid

C8H16N2O4S2 (268.0551)


   

zardaverine

6-[4-(difluoromethoxy)-3-methoxyphenyl]-2,3-dihydropyridazin-3-one

C12H10F2N2O3 (268.0659)


D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents > D001993 - Bronchodilator Agents C78273 - Agent Affecting Respiratory System > C29712 - Anti-asthmatic Agent > C319 - Bronchodilator D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents D004791 - Enzyme Inhibitors > D010726 - Phosphodiesterase Inhibitors C471 - Enzyme Inhibitor > C744 - Phosphodiesterase Inhibitor

   

(-)-medicarpin

14-methoxy-8,17-dioxatetracyclo[8.7.0.0²,⁷.0¹¹,¹⁶]heptadeca-2,4,6,9,11,13,15-heptaen-5-ol

C16H12O4 (268.0736)


(-)-medicarpin is a member of the class of compounds known as isoflavonoids. Isoflavonoids are natural products derived from 3-phenylchromen-4-one (-)-medicarpin is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). (-)-medicarpin can be found in a number of food items such as oriental wheat, arrowroot, french plantain, and grape, which makes (-)-medicarpin a potential biomarker for the consumption of these food products.

   

Techtochrysin

5-Hydroxy-7-methylflavone; 7-O-Methylchrysin; Tectochrysine

C16H12O4 (268.0736)


Tectochrysin is a monohydroxyflavone that is flavone substituted by a hydroxy group at position 4 and a methoxy group at position 7 respectively. It has a role as a plant metabolite, an antidiarrhoeal drug and an antineoplastic agent. It is a monohydroxyflavone and a monomethoxyflavone. It is functionally related to a flavone. Tectochrysin is a natural product found in Hedychium spicatum, Populus laurifolia, and other organisms with data available. A monohydroxyflavone that is flavone substituted by a hydroxy group at position 4 and a methoxy group at position 7 respectively. Tectochrysin (Techtochrysin) is one of the major flavonoids of Alpinia oxyphylla Miquel. Tectochrysin inhibits activity of NF-κB. Tectochrysin (Techtochrysin) is one of the major flavonoids of Alpinia oxyphylla Miquel. Tectochrysin inhibits activity of NF-κB.

   

Pratol

4H-1-Benzopyran-4-one, 7-hydroxy-2-(4-methoxyphenyl)-

C16H12O4 (268.0736)


   

Lespedezol A1

9-Hydroxyfurano[23:3,2]pterocarpene

C16H12O4 (268.0736)


   

ANEMARCOUMARIN A

ANEMARCOUMARIN A

C16H12O4 (268.0736)


   
   

Rubiadin 1-methyl ether

Rubiadin-1-methyl ether

C16H12O4 (268.0736)


Rubiadin-1-methyl ether is a natural anthraquinone isolated from Morinda officinalis How, and inhibits osteoclastic bone resorption via inhibition on the phosphorylation of NF-κB p65 and the degradation of IκBα as well as decrease in the nuclear translocation of p65[1]. Rubiadin-1-methyl ether is a natural anthraquinone isolated from Morinda officinalis How, and inhibits osteoclastic bone resorption via inhibition on the phosphorylation of NF-κB p65 and the degradation of IκBα as well as decrease in the nuclear translocation of p65[1].

   

Rubiawallin B

Rubiawallin B

C16H12O4 (268.0736)


   

Cirrhopetalin

7-hydroxy-4-methoxy-2,3-methylenedioxyphenanthrene

C16H12O4 (268.0736)


   

7-Hydroxy-8-methoxy-2-methylanthraquinone

7-Hydroxy-8-methoxy-2-methylanthraquinone

C16H12O4 (268.0736)


   

Strobochrysin

5,7-Dihydroxy-6-methyl-2-phenyl-4H-1-benzopyran-4-one

C16H12O4 (268.0736)


   

5-Hydroxy-6-methoxyflavone

5-Hydroxy-6-methoxyflavone

C16H12O4 (268.0736)


   

5-hydroxy-2-methoxyflavone

5-hydroxy-2-methoxyflavone

C16H12O4 (268.0736)


   

6-Hydroxy-4-methoxyflavone

6-Hydroxy-4-methoxyflavone

C16H12O4 (268.0736)


   

Isopratol

4-Hydroxy-7-methoxyflavone

C16H12O4 (268.0736)


   

4-Methoxyflavonol

3-Hydroxy-4-methoxyflavone

C16H12O4 (268.0736)


relative retention time with respect to 9-anthracene Carboxylic Acid is 1.247 relative retention time with respect to 9-anthracene Carboxylic Acid is 1.249

   

5-Hydroxy-7-methoxyisoflavone

5-Hydroxy-7-methoxyisoflavone

C16H12O4 (268.0736)


   

Pallidiflorin

5-Hydroxy-4-methoxyisoflavone

C16H12O4 (268.0736)


   

Isodalbergin

7-Hydroxy-6-methoxy-4-phenylcoumarin

C16H12O4 (268.0736)


   

Dalbergin

2H-1-Benzopyran-2-one, 6-hydroxy-7-methoxy-4-phenyl-

C16H12O4 (268.0736)


Dalbergin is a neoflavonoid. Dalbergin is a natural product found in Dalbergia cochinchinensis, Pterocarpus santalinus, and other organisms with data available.

   

Biochanin B

4H-1-Benzopyran-4-one, 7-hydroxy-3-(4-methoxyphenyl)- (9CI)

C16H12O4 (268.0736)


D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D004967 - Estrogens Formononetin is a potent FGFR2 inhibitor with an IC50 of ~4.31 μM. Formononetin potently inhibits angiogenesis and tumor growth[1]. Formononetin is a potent FGFR2 inhibitor with an IC50 of ~4.31 μM. Formononetin potently inhibits angiogenesis and tumor growth[1].

   

Trigraecum

7-Hydroxy-6-methoxyflavone

C16H12O4 (268.0736)


   

Isoformononetin

4H-1-Benzopyran-4-one, 3-(4-hydroxyphenyl)-7-methoxy-

C16H12O4 (268.0736)


Isoformononetin is an analog of Daidzein (HY-N0019) and has immunoprotective effects. Isoformononetin inhibits the differentiation of Th17 and B-cells lymphopoesis to promote osteogenesis in estrogen-deficient bone loss conditions[1]. Isoformononetin is an analog of Daidzein (HY-N0019) and has immunoprotective effects. Isoformononetin inhibits the differentiation of Th17 and B-cells lymphopoesis to promote osteogenesis in estrogen-deficient bone loss conditions[1].

   

N-(3-Cyano-4,5-dihydronaphtho[1,2-b]thiophen-2-yl)acetamide

N-(3-Cyano-4,5-dihydronaphtho[1,2-b]thiophen-2-yl)acetamide

C15H12N2OS (268.067)


   

1,4-Dimethoxyanthraquinone

1,4-Dimethoxyanthraquinone

C16H12O4 (268.0736)


   

zardaverine

zardaverine

C12H10F2N2O3 (268.0659)


D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents > D001993 - Bronchodilator Agents C78273 - Agent Affecting Respiratory System > C29712 - Anti-asthmatic Agent > C319 - Bronchodilator D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents D004791 - Enzyme Inhibitors > D010726 - Phosphodiesterase Inhibitors C471 - Enzyme Inhibitor > C744 - Phosphodiesterase Inhibitor

   

3-Methoxyflavonol

3-HYDROXY-3-METHOXYFLAVONE

C16H12O4 (268.0736)


relative retention time with respect to 9-anthracene Carboxylic Acid is 1.241 relative retention time with respect to 9-anthracene Carboxylic Acid is 1.240 relative retention time with respect to 9-anthracene Carboxylic Acid is 1.247 3'-Methoxyflavonol is a selective agonist of neuromedin U 2 receptor (NMU2R).

   

7-HYDROXY-3-METHOXYFLAVONE

7-HYDROXY-3-METHOXYFLAVONE

C16H12O4 (268.0736)


relative retention time with respect to 9-anthracene Carboxylic Acid is 1.167 relative retention time with respect to 9-anthracene Carboxylic Acid is 1.168 relative retention time with respect to 9-anthracene Carboxylic Acid is 1.162 relative retention time with respect to 9-anthracene Carboxylic Acid is 1.164

   

5-HYDROXY-3-METHOXYFLAVONE

5-HYDROXY-3-METHOXYFLAVONE

C16H12O4 (268.0736)


relative retention time with respect to 9-anthracene Carboxylic Acid is 1.313 relative retention time with respect to 9-anthracene Carboxylic Acid is 1.314

   

7-HYDROXY-2-METHOXYFLAVONE

7-HYDROXY-2-METHOXYFLAVONE

C16H12O4 (268.0736)


   

7-hydroxy-3-(4-methoxyphenyl)-2H-chromen-2-one

7-hydroxy-3-(4-methoxyphenyl)-2H-chromen-2-one

C16H12O4 (268.0736)


   

MEGxp0_001760

MEGxp0_001760

C16H12O4 (268.0736)


   

6-methoxyflavonol

3-Hydroxy-6-methoxyflavone

C16H12O4 (268.0736)


   

7-Methoxyflavonol

4H-1-Benzopyran-4-one,3-hydroxy-7-methoxy-2-phenyl-

C16H12O4 (268.0736)


   

SCHEMBL16227229

SCHEMBL16227229

C16H12O4 (268.0736)


   

5,7-Dihydroxy-8-methylflavone

5,7-Dihydroxy-8-methylflavone

C16H12O4 (268.0736)


   

1-Hydroxy-5-methoxy-2-methylanthracene-9,10-dione

1-Hydroxy-5-methoxy-2-methylanthracene-9,10-dione

C16H12O4 (268.0736)


   

1-Oxo-5-Hydroxy-6-methoxy-2-methyl-3-phenylbenzofuran

1-Oxo-5-Hydroxy-6-methoxy-2-methyl-3-phenylbenzofuran

C16H12O4 (268.0736)


   

1,8-Dimethoxyanthraquinone

1,8-Dimethoxyanthraquinone

C16H12O4 (268.0736)


   

2,7-Dimethylchrysazin

2,7-Dimethylchrysazin

C16H12O4 (268.0736)


   

DTXSID70805928

DTXSID70805928

C16H12O4 (268.0736)


   

4-Hydroxy-3-Methoxyflavone

4-Hydroxy-3-Methoxyflavone

C16H12O4 (268.0736)


   

228574-06-9

228574-06-9

C16H12O4 (268.0736)


   

1-hydroxy-6-methoxy-8-methyl-anthraquinone

1-hydroxy-6-methoxy-8-methyl-anthraquinone

C16H12O4 (268.0736)


   

6H-Benzofuro[3,2-c][1]benzopyran-9-ol, 6a,11a-dihydro-3-methoxy-, (6aR-cis)-; (6aR,11aR)-6a,11a-Dihydro-3-methoxy-6H-benzofuro[3,2-c][1]benzopyran-9-ol; 3-Methoxy-9-hydroxypterocarpan

6H-Benzofuro[3,2-c][1]benzopyran-9-ol, 6a,11a-dihydro-3-methoxy-, (6aR-cis)-; (6aR,11aR)-6a,11a-Dihydro-3-methoxy-6H-benzofuro[3,2-c][1]benzopyran-9-ol; 3-Methoxy-9-hydroxypterocarpan

C16H12O4 (268.0736)


   

2,3-Dimethoxyanthracene-9,10-dione

2,3-Dimethoxyanthracene-9,10-dione

C16H12O4 (268.0736)


   

SCHEMBL11921338

SCHEMBL11921338

C16H12O4 (268.0736)


   

1-Hydroxy-6-methoxy-3-methylanthrachinon|6-Me ether-Phomarin|phomarin 6-methyl ether|Phomarin-6-methylether

1-Hydroxy-6-methoxy-3-methylanthrachinon|6-Me ether-Phomarin|phomarin 6-methyl ether|Phomarin-6-methylether

C16H12O4 (268.0736)


   

7-Hydroxy-3-(4-hydroxybenzylidene)chroman-4-one

7-Hydroxy-3-(4-hydroxybenzylidene)chroman-4-one

C16H12O4 (268.0736)


   

CHEMBL298539

CHEMBL298539

C16H12O4 (268.0736)


   

1-Hydroxy-3-methoxy-6-methylanthraquinone

1-Hydroxy-3-methoxy-6-methylanthraquinone

C16H12O4 (268.0736)


   

1-hydroxy-5-methoxy-3-methyl-9,10 dihydroanthracene 9,10-dione|1-Hydroxy-5-methoxy-3-methyl-anthrachinon|1-hydroxy-5-methoxy-3-methyl-anthraquinone|ziganein-5-methyl ether

1-hydroxy-5-methoxy-3-methyl-9,10 dihydroanthracene 9,10-dione|1-Hydroxy-5-methoxy-3-methyl-anthrachinon|1-hydroxy-5-methoxy-3-methyl-anthraquinone|ziganein-5-methyl ether

C16H12O4 (268.0736)


   

rosellisin aldehyde

rosellisin aldehyde

C12H12O7 (268.0583)


   

SCHEMBL824463

SCHEMBL824463

C16H12O4 (268.0736)


   

Isooxoflavidinin

Isooxoflavidinin

C16H12O4 (268.0736)


   

SCHEMBL16932394

SCHEMBL16932394

C16H12O4 (268.0736)


   

Digitolutein

2-hydroxy-1-methoxy-3-methyl-anthracene-9,10-dione;4-Ethylcyclohexanone

C16H12O4 (268.0736)


Digitolutein is a natural product found in Digitalis isabelliana, Digitalis viridiflora, and other organisms with data available.

   

SCHEMBL5807605

SCHEMBL5807605

C12H12O7 (268.0583)


   

1-Hydroxy-8-methoxy-3-methylanthracene-9,10-dione

1-Hydroxy-8-methoxy-3-methylanthracene-9,10-dione

C16H12O4 (268.0736)


   

1-Hydroxy-2-methyl-6-methoxyanthraquinone

1-Hydroxy-2-methyl-6-methoxyanthraquinone

C16H12O4 (268.0736)


   

Hallachrome

Hallachrome

C16H12O4 (268.0736)


   

6-(3,4-dihydroxyphenyl)naphthalene-2,3-diol

6-(3,4-dihydroxyphenyl)naphthalene-2,3-diol

C16H12O4 (268.0736)


   

(1S,5R,6R)-5,6-dihydroxy-3-(hydroxymethyl)-2-oxocyclohex-3-en-1-yl furan-2-carboxylate|epoxydine B

(1S,5R,6R)-5,6-dihydroxy-3-(hydroxymethyl)-2-oxocyclohex-3-en-1-yl furan-2-carboxylate|epoxydine B

C12H12O7 (268.0583)


   
   

1-hydroxy-7-methoxy-3-methylanthraquinone

1-hydroxy-7-methoxy-3-methylanthraquinone

C16H12O4 (268.0736)


   

1,2-dimethoxyanthracene-9,10-dione

1,2-dimethoxyanthracene-9,10-dione

C16H12O4 (268.0736)


   

1-hydroxy-2-methoxy-6-methyl-anthracene-9,10-dione

1-hydroxy-2-methoxy-6-methyl-anthracene-9,10-dione

C16H12O4 (268.0736)


   

5-hydroxy-8-methoxyflavone

5-hydroxy-8-methoxyflavone

C16H12O4 (268.0736)


   

SCHEMBL12304029

SCHEMBL12304029

C16H12O4 (268.0736)


   

3-(4-hydroxy-phenyl)-7-methoxy-chromen-2-one|3-(p-hydroxyphenyl)-7-methoxycoumarin|7-Methoxy-4-hydroxy-3-phenylcoumarin

3-(4-hydroxy-phenyl)-7-methoxy-chromen-2-one|3-(p-hydroxyphenyl)-7-methoxycoumarin|7-Methoxy-4-hydroxy-3-phenylcoumarin

C16H12O4 (268.0736)


   

6-hydroxy-8-methoxy-3-methyl-1,8-anthraquinone

6-hydroxy-8-methoxy-3-methyl-1,8-anthraquinone

C16H12O4 (268.0736)


   

(-)-Medicarpin

(-)-Medicarpin

C16H12O4 (268.0736)


   

Oxoflavidinin

Oxoflavidinin

C16H12O4 (268.0736)


   

6-HYDROXY-7-METHOXYFLAVONE

6-HYDROXY-7-METHOXYFLAVONE

C16H12O4 (268.0736)


   

DTXSID50631686

DTXSID50631686

C16H12O4 (268.0736)


   

Swerilactone E

Swerilactone E

C16H12O4 (268.0736)


   
   
   

2-hydroxy-7-methoxyflavone

2-hydroxy-7-methoxyflavone

C16H12O4 (268.0736)


   

Vesparion|Vesparione

Vesparion|Vesparione

C16H12O4 (268.0736)


   

2-Aethoxy-1-hydroxy-anthrachinon|2-ethoxy-1-hydroxy-anthraquinone|2-ethoxy-1-hydroxyanthracene-9,10-dione|2-ethoxy-1-hydroxyanthraquinone

2-Aethoxy-1-hydroxy-anthrachinon|2-ethoxy-1-hydroxy-anthraquinone|2-ethoxy-1-hydroxyanthracene-9,10-dione|2-ethoxy-1-hydroxyanthraquinone

C16H12O4 (268.0736)


   

MLS001173231

MLS001173231

C16H12O4 (268.0736)


   

CHEMBL125765

CHEMBL125765

C16H12O4 (268.0736)


   

tetramethoxy-phthalic acid anhydride

tetramethoxy-phthalic acid anhydride

C12H12O7 (268.0583)


   

2,6-Dimethylanthrarufin

2,6-Dimethylanthrarufin

C16H12O4 (268.0736)


   

Tanshinlactone A

Tanshinlactone A

C16H12O4 (268.0736)


   

1-Hydroxy-2-methoxy-7-methylanthraquinone

1-Hydroxy-2-methoxy-7-methylanthraquinone

C16H12O4 (268.0736)


   

6-Methoxy-5H-4-oxa-pyrene-2,7-diol

6-Methoxy-5H-4-oxa-pyrene-2,7-diol

C16H12O4 (268.0736)


   

4H-1-Benzopyran-4-one, 7-hydroxy-3-methoxy-2-phenyl-

4H-1-Benzopyran-4-one, 7-hydroxy-3-methoxy-2-phenyl-

C16H12O4 (268.0736)


   

3-HYDROXY-5-METHOXYFLAVONE

3-HYDROXY-5-METHOXYFLAVONE

C16H12O4 (268.0736)


   

Methylchrysin

Methylchrysin

C16H12O4 (268.0736)


   

7-hydroxy-3-(2-methoxyphenyl)-4H-chromen-4-one

7-hydroxy-3-(2-methoxyphenyl)-4H-chromen-4-one

C16H12O4 (268.0736)


   

AG-183

2-amino-4-(3,4,5-trihydroxyphenyl)-1,3-butadiene-1,1,3-tricarbonitrile

C13H8N4O3 (268.0596)


   

MK2IXH6AUE

9,10-Anthracenedione, 3-hydroxy-1-methoxy-2-methyl-

C16H12O4 (268.0736)


Rubiadin 1-methyl ether is a natural product found in Prismatomeris tetrandra, Coprosma areolata, and other organisms with data available. Rubiadin-1-methyl ether is a natural anthraquinone isolated from Morinda officinalis How, and inhibits osteoclastic bone resorption via inhibition on the phosphorylation of NF-κB p65 and the degradation of IκBα as well as decrease in the nuclear translocation of p65[1]. Rubiadin-1-methyl ether is a natural anthraquinone isolated from Morinda officinalis How, and inhibits osteoclastic bone resorption via inhibition on the phosphorylation of NF-κB p65 and the degradation of IκBα as well as decrease in the nuclear translocation of p65[1].

   

Isoformononetin

4H-1-Benzopyran-4-one, 3-(4-hydroxyphenyl)-7-methoxy-

C16H12O4 (268.0736)


Isoformononetin is a methoxyisoflavone that is isoflavone substituted at positions 4 and 7 by hydroxy and methoxy groups respectively. It has a role as a metabolite, a bone density conservation agent and an apoptosis inhibitor. It is a hydroxyisoflavone and a member of 7-methoxyisoflavones. It is functionally related to a daidzein. Isoformononetin is a natural product found in Oxytropis falcata, Arabidopsis thaliana, and other organisms with data available. A methoxyisoflavone that is isoflavone substituted at positions 4 and 7 by hydroxy and methoxy groups respectively. Isoformononetin is found in pulses. Isoformononetin is isolated from soybean (Glycine max) and other plants. Isolated from soybean (Glycine max) and other plants. Isoformononetin is found in soy bean and pulses. Isoformononetin is an analog of Daidzein (HY-N0019) and has immunoprotective effects. Isoformononetin inhibits the differentiation of Th17 and B-cells lymphopoesis to promote osteogenesis in estrogen-deficient bone loss conditions[1]. Isoformononetin is an analog of Daidzein (HY-N0019) and has immunoprotective effects. Isoformononetin inhibits the differentiation of Th17 and B-cells lymphopoesis to promote osteogenesis in estrogen-deficient bone loss conditions[1].

   

8-Methyl Chrysophanol

9,10-Anthracenedione, 1-hydroxy-8-methoxy-3-methyl-

C16H12O4 (268.0736)


1-Hydroxy-8-methoxy-3-methylanthracene-9,10-dione is a natural product found in Ventilago denticulata, Aloe debrana, and other organisms with data available.

   

Formononetin

Formononetin (Biochanin B)

C16H12O4 (268.0736)


Annotation level-1 D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D004967 - Estrogens relative retention time with respect to 9-anthracene Carboxylic Acid is 1.059 relative retention time with respect to 9-anthracene Carboxylic Acid is 1.061 Formononetin is a potent FGFR2 inhibitor with an IC50 of ~4.31 μM. Formononetin potently inhibits angiogenesis and tumor growth[1]. Formononetin is a potent FGFR2 inhibitor with an IC50 of ~4.31 μM. Formononetin potently inhibits angiogenesis and tumor growth[1].

   

(5-Hydroxy-benzofuran-3-yl)-(4-methoxy-phenyl)-methanone

NCGC00160339-01!(5-Hydroxy-benzofuran-3-yl)-(4-methoxy-phenyl)-methanone

C16H12O4 (268.0736)


   

Homocystine

4,4-Dithiobis[2-aminobutyric Acid]

C8H16N2O4S2 (268.0551)


An organic disulfide obtained by oxidative dimerisation of homocysteine. 4,4'-Disulfanediylbis(2-aminobutanoic acid) is an endogenous metabolite.

   

L-Homocystine

4,4-Dithiobis[2-aminobutyric Acid]

C8H16N2O4S2 (268.0551)


A homocystine in which both chiral centres have L configuration. 4,4'-Disulfanediylbis(2-aminobutanoic acid) is an endogenous metabolite. L-Homocystine is the oxidized member of the L-homocysteine. Homocysteine is a pro-thrombotic factor, vasodilation impairing agent, pro-inflammatory factor and endoplasmatic reticulum-stress inducer used to study cardiovascular disease mechanisms.

   

7-Hydroxy-4-methoxyflavone

7-Hydroxy-4-methoxyflavone

C16H12O4 (268.0736)


   

7-Methoxy-4-hydroxyflavone

7-Methoxy-4-hydroxyflavone

C16H12O4 (268.0736)


   

7-Hydroxy-3(4-methoxyphenyl) coumarin

7-Hydroxy-3(4-methoxyphenyl) coumarin

C16H12O4 (268.0736)


   

3-hydroxy-6-methoxy-2-phenylchromen-4-one

NCGC00168876-02!3-hydroxy-6-methoxy-2-phenylchromen-4-one

C16H12O4 (268.0736)


   

7-hydroxy-3-(4-methoxyphenyl)chromen-4-one

NCGC00017269-08!7-hydroxy-3-(4-methoxyphenyl)chromen-4-one

C16H12O4 (268.0736)


   

6-hydroxy-5-methoxy-2-phenylchromen-4-one

NCGC00385667-01!6-hydroxy-5-methoxy-2-phenylchromen-4-one

C16H12O4 (268.0736)


   

formononetine

formononetine

C16H12O4 (268.0736)


   

(2E)-2-[hydroxy(phenyl)methylidene]-6-methoxy-1-benzofuran-3-one

(2E)-2-[hydroxy(phenyl)methylidene]-6-methoxy-1-benzofuran-3-one

C16H12O4 (268.0736)


   

DALBERGIONE

DALBERGIONE

C16H12O4 (268.0736)


   

Isoflavone base + 1O, 1MeO

Isoflavone base + 1O, 1MeO

C16H12O4 (268.0736)


Annotation level-3

   

7-hydroxy-3-(4-methoxyphenyl)chromen-4-one [IIN-based on: CCMSLIB00000847610]

NCGC00017269-08!7-hydroxy-3-(4-methoxyphenyl)chromen-4-one [IIN-based on: CCMSLIB00000847610]

C16H12O4 (268.0736)


   

7-hydroxy-3-(4-methoxyphenyl)chromen-4-one [IIN-based: Match]

NCGC00017269-08!7-hydroxy-3-(4-methoxyphenyl)chromen-4-one [IIN-based: Match]

C16H12O4 (268.0736)


   

Homocystine; LC-tDDA; CE10

Homocystine; LC-tDDA; CE10

C8H16N2O4S2 (268.0551)


   

Homocystine; LC-tDDA; CE20

Homocystine; LC-tDDA; CE20

C8H16N2O4S2 (268.0551)


   

Homocystine; LC-tDDA; CE30

Homocystine; LC-tDDA; CE30

C8H16N2O4S2 (268.0551)


   

Homocystine; LC-tDDA; CE40

Homocystine; LC-tDDA; CE40

C8H16N2O4S2 (268.0551)


   

Homocystine; AIF; CE0; MS2Dec

Homocystine; AIF; CE0; MS2Dec

C8H16N2O4S2 (268.0551)


   

Homocystine; AIF; CE10; MS2Dec

Homocystine; AIF; CE10; MS2Dec

C8H16N2O4S2 (268.0551)


   

Homocystine; AIF; CE30; MS2Dec

Homocystine; AIF; CE30; MS2Dec

C8H16N2O4S2 (268.0551)


   

Penicillamine cysteine disulfide

Penicillamine cysteine disulfide

C8H16N2O4S2 (268.0551)


   

7-HYDROXY-2-METHOXYISOFLAVONE

7-HYDROXY-2-METHOXYISOFLAVONE

C16H12O4 (268.0736)


   

3-Hydroxy-4-methoxyflavone

3-Hydroxy-4-methoxyflavone

C16H12O4 (268.0736)


   

Hexanoyl dhap

Hexanoyl dihydroxyacetone phosphate;1-caproylglycerone 3-phosphate

C9H17O7P (268.0712)


   

Homolanthionine

Homolanthionine

C8H16N2O6S (268.0729)


   

Ala-Ala-OH

(S)-2-(3-methoxy-4-nitrobenzamido)propanoic acid

C11H12N2O6 (268.0695)


   

Abu-Gly-OH

2-(3-ethoxy-4-nitrobenzamido)acetic acid

C11H12N2O6 (268.0695)


   

Gly-Abu-OH

(S)-2-(3-hydroxy-4-nitrobenzamido)pentanoic acid

C11H12N2O6 (268.0695)


   

8-Hydroxy-1-methoxy-3-methylanthraquinone

8-hydroxy-1-methoxy-3-methyl-9,10-dihydroanthracene-9,10-dione

C16H12O4 (268.0736)


   

1,3-dimethoxyanthraquinone

1,3-dimethoxy-9,10-dihydroanthracene-9,10-dione

C16H12O4 (268.0736)


   

ziganein-1-methyl ether

5-Hydroxy-1-methoxy-3-methylanthracene-9,10-dione

C16H12O4 (268.0736)


   

2-MERCAPTO-3-M-TOLYL-3H-QUINAZOLIN-4-ONE

2-MERCAPTO-3-M-TOLYL-3H-QUINAZOLIN-4-ONE

C15H12N2OS (268.067)


   

2-MERCAPTO-3-O-TOLYL-3H-QUINAZOLIN-4-ONE

2-MERCAPTO-3-O-TOLYL-3H-QUINAZOLIN-4-ONE

C15H12N2OS (268.067)


   

METHYL 7-METHYL-9-OXO-9H-XANTHENE-1-CARBOXYLATE

METHYL 7-METHYL-9-OXO-9H-XANTHENE-1-CARBOXYLATE

C16H12O4 (268.0736)


   

4,4-Stilbenedicarboxylic acid

4,4-Stilbenedicarboxylic acid

C16H12O4 (268.0736)


   

8-Hydroxy-7-methoxyflavone

8-hydroxy-7-methoxy-2-phenylchromen-4-one

C16H12O4 (268.0736)


   

7-Hydroxy-5-methoxy-2-phenyl-chromen-4-one

7-Hydroxy-5-methoxy-2-phenyl-chromen-4-one

C16H12O4 (268.0736)


   

4(1H)-Quinazolinone,2,3-dihydro-3-(4-methylphenyl)-2-thioxo-

4(1H)-Quinazolinone,2,3-dihydro-3-(4-methylphenyl)-2-thioxo-

C15H12N2OS (268.067)


   

aprikalim

N-methyl-2-(pyridin-3-yl)tetrahydrothiopyran-2-carbothioamide 1-oxide

C12H16N2OS2 (268.0704)


   

Dimethyl cystinate

Dimethyl cystinate

C8H16N2O4S2 (268.0551)


   

2-Amino-3-(2-oxo-1,2-dihydroquinolin-4-yl)propanoic acid hydrochloride

2-Amino-3-(2-oxo-1,2-dihydroquinolin-4-yl)propanoic acid hydrochloride

C12H13ClN2O3 (268.0615)


   

1-(4-Bromophenyl)-4-ethylpiperazine

1-(4-Bromophenyl)-4-ethylpiperazine

C12H17BrN2 (268.0575)


   

Todralazine hydrochloride

Todralazine hydrochloride

C11H13ClN4O2 (268.0727)


D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents Todralazine hydrochloride (Ecarazine hydrochloride) is an anti-hypertensive agent, acts as a β2AR blocker, with antioxidant and free radical scavenging activity[1].

   

1-(4-BROMO-2-FLUOROBENZYL)-1,4-DIAZEPANE

1-(4-BROMO-2-FLUOROBENZYL)-1,4-DIAZEPANE

C12H17BrN2 (268.0575)


   

3-BUTYL-2-MERCAPTO-5,6-DIMETHYL-3H-THIENO[2,3-D]PYRIMIDIN-4-ONE

3-BUTYL-2-MERCAPTO-5,6-DIMETHYL-3H-THIENO[2,3-D]PYRIMIDIN-4-ONE

C12H16N2OS2 (268.0704)


   

4-(5-AMINO-1H-1,2,4-TRIAZOL-3-YLAMINO)-N-METHYLBENZENESULFONAMIDE

4-(5-AMINO-1H-1,2,4-TRIAZOL-3-YLAMINO)-N-METHYLBENZENESULFONAMIDE

C9H12N6O2S (268.0742)


   

5-Ethynyl uridine

5-Ethynyl uridine

C11H12N2O6 (268.0695)


5-Ethynyluridine (5-EU) is a potent cell-permeable nucleoside can be used to label newly synthesized RNA. 5-Ethynyluridine can be used for isolation and sequencing of nascent RNA from neuronal populations in vivo. 5-Ethynyluridine can be used to identify changes in transcription in vivo in nervous system disease models[1][2]. 5-Ethynyluridine is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.

   

Methyl 4-acetamido-2-methoxy-5-nitrobenzoate

Methyl 4-acetamido-2-methoxy-5-nitrobenzoate

C11H12N2O6 (268.0695)


   

2-(4-Acetoxyphenyl)benzothiophene

2-(4-Acetoxyphenyl)benzothiophene

C16H12O2S (268.0558)


   

4-(4-Phenoxy-phenyl)-thiazol-2-ylamine

4-(4-Phenoxy-phenyl)-thiazol-2-ylamine

C15H12N2OS (268.067)


   

4-Benzoyl-3-hydroxyphenyl acrylate

4-Benzoyl-3-hydroxyphenyl acrylate

C16H12O4 (268.0736)


   

N-(4-(2,5-Dioxo-4-oxazolidinyl)butyl)-2,2,2-trifluoroacetamide

N-(4-(2,5-Dioxo-4-oxazolidinyl)butyl)-2,2,2-trifluoroacetamide

C9H11F3N2O4 (268.0671)


   

C-(2-FLUORO-BIPHENYL-4-YL)-METHYLAMINEHYDROCHLORIDE

C-(2-FLUORO-BIPHENYL-4-YL)-METHYLAMINEHYDROCHLORIDE

C16H12O4 (268.0736)


   

3-benzyl-2-sulfanylidene-1H-quinazolin-4-one

3-benzyl-2-sulfanylidene-1H-quinazolin-4-one

C15H12N2OS (268.067)


   

6-hydroxy-2-(3-methoxyphenyl)chromen-4-one

6-hydroxy-2-(3-methoxyphenyl)chromen-4-one

C16H12O4 (268.0736)


   

6-HYDROXY-4-METHOXYFLAVONE

6-HYDROXY-4-METHOXYFLAVONE

C16H12O4 (268.0736)


   

dimethylphenacylsulfonium tetrafluoroborate

dimethylphenacylsulfonium tetrafluoroborate

C10H13BF4OS (268.0716)


   

N,N-Ethylenedi-L-cysteine

N,N-Ethylenedi-L-cysteine

C8H16N2O4S2 (268.0551)


   

1,5-Dimethoxyanthraquinone

1,5-Dimethoxyanthraquinone

C16H12O4 (268.0736)


   

4-HYDROXY-6-METHOXYFLAVONE

4-HYDROXY-6-METHOXYFLAVONE

C16H12O4 (268.0736)


   

1-OXO-3-PHENYL-3,4-DIHYDRO-1H-ISOCHROMENE-4-CARBOXYLIC ACID

1-OXO-3-PHENYL-3,4-DIHYDRO-1H-ISOCHROMENE-4-CARBOXYLIC ACID

C16H12O4 (268.0736)


   

3-(2-aminoethylsulfanyl)-1-(4-fluorophenyl)pyrrolidine-2,5-dione

3-(2-aminoethylsulfanyl)-1-(4-fluorophenyl)pyrrolidine-2,5-dione

C12H13FN2O2S (268.0682)


   

3-(1,3-Benzodioxol-5-yl)-1-(4-hydroxyphenyl)-2-propen-1-one

3-(1,3-Benzodioxol-5-yl)-1-(4-hydroxyphenyl)-2-propen-1-one

C16H12O4 (268.0736)


   

4-HYDROXY-7-METHOXY-3-PHENYLCOUMARIN 9&

4-HYDROXY-7-METHOXY-3-PHENYLCOUMARIN 9&

C16H12O4 (268.0736)


   

5,5-DIPHENYL-2-THIOHYDANTOIN

5,5-DIPHENYL-2-THIOHYDANTOIN

C15H12N2OS (268.067)


   

3-(phenoxymethyl)-1-benzofuran-2-carboxylic acid

3-(phenoxymethyl)-1-benzofuran-2-carboxylic acid

C16H12O4 (268.0736)


   

Ethyl 6-chloro-5-ethoxy-1H-pyrrolo[2,3-b]pyridine-2-carboxylate

Ethyl 6-chloro-5-ethoxy-1H-pyrrolo[2,3-b]pyridine-2-carboxylate

C12H13ClN2O3 (268.0615)


   

1-(2-Bromoethyl)-4-phenylpiperazine

1-(2-Bromoethyl)-4-phenylpiperazine

C12H17BrN2 (268.0575)


   

6-mercaptopurine-2-deoxyriboside

6-mercaptopurine-2-deoxyriboside

C10H12N4O3S (268.063)


   

Butanoic acid,4,4-dithiobis[2-amino-, (2R,2R)-

Butanoic acid,4,4-dithiobis[2-amino-, (2R,2R)-

C8H16N2O4S2 (268.0551)


   

5-Bromo-N-cyclohexyl-N-methylpyridin-2-amine

5-Bromo-N-cyclohexyl-N-methylpyridin-2-amine

C12H17BrN2 (268.0575)


   

tetramethyllead

tetramethyllead

C4H12Pb (268.0705)


   

2-(11-oxo-6H-benzo[c][1]benzoxepin-3-yl)acetic acid

2-(11-oxo-6H-benzo[c][1]benzoxepin-3-yl)acetic acid

C16H12O4 (268.0736)


   

7-Methoxy-8-hydroxy-4-phenylcoumarin

7-Methoxy-8-hydroxy-4-phenylcoumarin

C16H12O4 (268.0736)


   

3-hydroxy-2-(2-methoxyphenyl)chromen-4-one

3-hydroxy-2-(2-methoxyphenyl)chromen-4-one

C16H12O4 (268.0736)


   

1-(3-Bromobenzyl)-4-methylpiperazine

1-(3-Bromobenzyl)-4-methylpiperazine

C12H17BrN2 (268.0575)


   

1-ACETYL-6,6-DIMETHYL-3-(METHYLTHIO)-4,5,6,7-TETRAHYDROBENZO[C]THIOPHEN-4-ONE

1-ACETYL-6,6-DIMETHYL-3-(METHYLTHIO)-4,5,6,7-TETRAHYDROBENZO[C]THIOPHEN-4-ONE

C13H16O2S2 (268.0592)


   

1-iodo-Decane

1-iodo-Decane

C10H21I (268.0688)


   

4-HYDROXY-5-METHOXYFLAVONE

4-HYDROXY-5-METHOXYFLAVONE

C16H12O4 (268.0736)


   

ALANINE RACEMASE

ALANINE RACEMASE

C11H12N2O6 (268.0695)


   

4-(2-Methylpropoxy)-1,3-benzenedicarbothioamide

4-(2-Methylpropoxy)-1,3-benzenedicarbothioamide

C12H16N2OS2 (268.0704)


   

Apotryptophanase from Escherichia coli

Apotryptophanase from Escherichia coli

C11H12N2O6 (268.0695)


   

1-vinyl-3-ethyliMidazoliuM hexafluorophosphate

1-vinyl-3-ethyliMidazoliuM hexafluorophosphate

C7H11F6N2P (268.0564)


   

9,10-Anthracenedione,1,4-dihydroxy-2,3-dimethyl-

9,10-Anthracenedione,1,4-dihydroxy-2,3-dimethyl-

C16H12O4 (268.0736)


   

ethyl 2-[(2-chlorophenyl)hydrazinylidene]-3-oxo-butanoate

ethyl 2-[(2-chlorophenyl)hydrazinylidene]-3-oxo-butanoate

C12H13ClN2O3 (268.0615)


   

1-(3-bromophenyl)-N-methylpiperidin-4-amine

1-(3-bromophenyl)-N-methylpiperidin-4-amine

C12H17BrN2 (268.0575)


   

1-HYDROXY-2-METHOXY-3-METHYL-ANTHRAQUINONE

1-HYDROXY-2-METHOXY-3-METHYL-ANTHRAQUINONE

C16H12O4 (268.0736)


   

Isoxepac

Isoxepac

C16H12O4 (268.0736)


C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic

   

1-(4-Bromobenzyl)-4-methylpiperazine

1-(4-Bromobenzyl)-4-methylpiperazine

C12H17BrN2 (268.0575)


   

4-(3,4-DIFLUOROPHENYL)-1,2,3,4-TETRAHYDRO-6-METHYL-2-OXO-5-PYRIMIDINECARBOXYLIC

4-(3,4-DIFLUOROPHENYL)-1,2,3,4-TETRAHYDRO-6-METHYL-2-OXO-5-PYRIMIDINECARBOXYLIC

C12H10F2N2O3 (268.0659)


   

tert-Butyl 3,5-dinitrobenzoate

tert-Butyl 3,5-dinitrobenzoate

C11H12N2O6 (268.0695)


   

Dazoxiben hydrochloride

Dazoxiben hydrochloride

C12H13ClN2O3 (268.0615)


C78275 - Agent Affecting Blood or Body Fluid > C29750 - Thrombolytic Agent D004791 - Enzyme Inhibitors

   
   

2-Amino-4-(3-amino-3-carboxypropyl)sulfonylbutanoic acid

2-Amino-4-(3-amino-3-carboxypropyl)sulfonylbutanoic acid

C8H16N2O6S (268.0729)


   

6-(2,5-Dioxotetrahydrofuran-3-yl)-4-methyltetrahydro-1H-furo[3,4-c]pyran-1,3(6H)-dione

6-(2,5-Dioxotetrahydrofuran-3-yl)-4-methyltetrahydro-1H-furo[3,4-c]pyran-1,3(6H)-dione

C12H12O7 (268.0583)


   

Tyrphostin A51

Tyrphostin A51

C13H8N4O3 (268.0596)


   

acetic acid (11-oxo-6H-benzo[c][1]benzoxepin-2-yl) ester

acetic acid (11-oxo-6H-benzo[c][1]benzoxepin-2-yl) ester

C16H12O4 (268.0736)


   

(5-Hydroxy-1-benzofuran-3-yl)(4-methoxyphenyl)methanone

(5-Hydroxy-1-benzofuran-3-yl)(4-methoxyphenyl)methanone

C16H12O4 (268.0736)


   

4H-1-Benzopyran-4-one, 2-(1,3-benzodioxol-5-yl)-2,3-dihydro-

4H-1-Benzopyran-4-one, 2-(1,3-benzodioxol-5-yl)-2,3-dihydro-

C16H12O4 (268.0736)


   

5-Imino-4-(3-trifluoromethyl-phenylazo)-5H-pyrazol-3-ylamine

5-Imino-4-(3-trifluoromethyl-phenylazo)-5H-pyrazol-3-ylamine

C10H7F3N6 (268.0684)


   

5-Imino-4-(2-trifluoromethyl-phenylazo)-5H-pyrazol-3-ylamine

5-Imino-4-(2-trifluoromethyl-phenylazo)-5H-pyrazol-3-ylamine

C10H7F3N6 (268.0684)


   

2-[(2,3,4-Trifluorobiphenyl-2-Yl)oxy]ethanol

2-[(2,3,4-Trifluorobiphenyl-2-Yl)oxy]ethanol

C14H11F3O2 (268.0711)


   

Furobufen

Furobufen

C16H12O4 (268.0736)


C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic

   

7-Hydroxy-3-(4-methoxyphenyl)chromen-2-one

7-Hydroxy-3-(4-methoxyphenyl)chromen-2-one

C16H12O4 (268.0736)


   
   

delta-N-(phosphonacetyl)-L-ornithine

delta-N-(phosphonacetyl)-L-ornithine

C7H15N3O6P- (268.0698)


   

4,4-Disulfanediylbis(2-ammoniobutanoate)

4,4-Disulfanediylbis(2-ammoniobutanoate)

C8H16N2O4S2 (268.0551)


   

N-(2-methyl-1,3-benzothiazol-6-yl)benzamide

N-(2-methyl-1,3-benzothiazol-6-yl)benzamide

C15H12N2OS (268.067)


   

N-(1,3-benzothiazol-2-yl)-N-methylbenzamide

N-(1,3-benzothiazol-2-yl)-N-methylbenzamide

C15H12N2OS (268.067)


   

4-(4-Phenylmethoxyphenyl)thiadiazole

4-(4-Phenylmethoxyphenyl)thiadiazole

C15H12N2OS (268.067)


   

Ethyl 2-oxobenzo[h]chromene-3-carboxylate

Ethyl 2-oxobenzo[h]chromene-3-carboxylate

C16H12O4 (268.0736)


   

2-(4-Methoxyphenyl)-2-oxoethyl Dithiobutyrate

2-(4-Methoxyphenyl)-2-oxoethyl Dithiobutyrate

C13H16O2S2 (268.0592)


   

1-Caproyl-sn-glycero-3-phosphate(2-)

1-Caproyl-sn-glycero-3-phosphate(2-)

C9H17O7P-2 (268.0712)


   

7-Hydroxy-8-methoxy-flavone

7-Hydroxy-8-methoxy-flavone

C16H12O4 (268.0736)


   

3-(6,7-Dimethoxy-1,3-benzodioxol-5-yl)oxirane-2-carboxylic acid

3-(6,7-Dimethoxy-1,3-benzodioxol-5-yl)oxirane-2-carboxylic acid

C12H12O7 (268.0583)


   

(R)-N-acetyl-S-benzyl-L-cysteine sulfoxide

(R)-N-acetyl-S-benzyl-L-cysteine sulfoxide

C12H14NO4S- (268.0644)


   

Benzoic acid, 4-acetylthio-, trimethylsilyl ester

Benzoic acid, 4-acetylthio-, trimethylsilyl ester

C12H16O3SSi (268.0589)


   

Benzoic acid, 3-acetylthio-, trimethylsilyl ester

Benzoic acid, 3-acetylthio-, trimethylsilyl ester

C12H16O3SSi (268.0589)


   

5-Methoxy-6-hydroxyflavone

5-Methoxy-6-hydroxyflavone

C16H12O4 (268.0736)


   

Portulacaxanthin III

Portulacaxanthin III

C11H12N2O6 (268.0695)


   

L,L-homocystine zwitterion

L,L-homocystine zwitterion

C8H16N2O4S2 (268.0551)


   

(2S)-2-amino-4-[(3-amino-3-carboxypropyl)disulfanyl]butanoic acid

(2S)-2-amino-4-[(3-amino-3-carboxypropyl)disulfanyl]butanoic acid

C8H16N2O4S2 (268.0551)


   

[3-(hexanoyloxy)-2-oxopropoxy]phosphonic acid

[3-(hexanoyloxy)-2-oxopropoxy]phosphonic acid

C9H17O7P (268.0712)


   

1-Caproyl-sn-glycero-3-phosphate(2-)

1-Caproyl-sn-glycero-3-phosphate(2-)

C9H17O7P (268.0712)


A 1-acyl-sn-glycero-3-phosphate(2-) in which the acyl group is specified as caproyl (hexanoyl).

   

6-Hydroxy-2-(4-hydroxyphenyl)-3-benzofuranyl methyl ketone

1-(6-Hydroxy-2-(4-hydroxyphenyl)-1-benzofuran-3-yl)ethanone

C16H12O4 (268.0736)


   

homocystine zwitterion

homocystine zwitterion

C8H16N2O4S2 (268.0551)


Dizwitterionic form of homocystine arising from transfer of two protons from the carboxy to the amino groups; major species at pH 7.3.

   

(3e)-7-hydroxy-3-[(4-hydroxyphenyl)methylidene]-2h-1-benzopyran-4-one

(3e)-7-hydroxy-3-[(4-hydroxyphenyl)methylidene]-2h-1-benzopyran-4-one

C16H12O4 (268.0736)


   

5-hydroxy-2-(2-methoxyphenyl)chromen-4-one

5-hydroxy-2-(2-methoxyphenyl)chromen-4-one

C16H12O4 (268.0736)


   

2-hydroxy-1-methoxy-7-methylanthracene-9,10-dione

2-hydroxy-1-methoxy-7-methylanthracene-9,10-dione

C16H12O4 (268.0736)


   

8-hydroxy-3-(4-hydroxyphenyl)-7-methylchromen-4-one

8-hydroxy-3-(4-hydroxyphenyl)-7-methylchromen-4-one

C16H12O4 (268.0736)


   

1-hydroxy-3-methoxy-6-methylanthracene-9,10-dione

1-hydroxy-3-methoxy-6-methylanthracene-9,10-dione

C16H12O4 (268.0736)


   

(12s)-4-hydroxy-11-oxatetracyclo[8.7.0.0³,⁸.0¹²,¹⁶]heptadeca-1(10),3,5,7,16-pentaene-2,9-dione

(12s)-4-hydroxy-11-oxatetracyclo[8.7.0.0³,⁸.0¹²,¹⁶]heptadeca-1(10),3,5,7,16-pentaene-2,9-dione

C16H12O4 (268.0736)


   

1-hydroxy-2-methoxy-7-methylanthracene-9,10-dione

1-hydroxy-2-methoxy-7-methylanthracene-9,10-dione

C16H12O4 (268.0736)


   

5-methoxy-2-oxatetracyclo[6.6.2.0⁴,¹⁶.0¹¹,¹⁵]hexadeca-1(14),4,6,8(16),9,11(15),12-heptaene-6,13-diol

5-methoxy-2-oxatetracyclo[6.6.2.0⁴,¹⁶.0¹¹,¹⁵]hexadeca-1(14),4,6,8(16),9,11(15),12-heptaene-6,13-diol

C16H12O4 (268.0736)


   

1-hydroxy-4-methoxy-2-methylanthracene-9,10-dione

1-hydroxy-4-methoxy-2-methylanthracene-9,10-dione

C16H12O4 (268.0736)


   

1, 3-dihydroxy-2-methylanthraguinone

NA

C16H12O4 (268.0736)


{"Ingredient_id": "HBIN001186","Ingredient_name": "1, 3-dihydroxy-2-methylanthraguinone","Alias": "NA","Ingredient_formula": "C16H12O4","Ingredient_Smile": "CC1=C(C=C2C(=C1OC)C(=O)C3=CC=CC=C3C2=O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "41923","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

1-hydroxy-3-methoxy-2-methylanthraquinone

NA

C16H12O4 (268.0736)


{"Ingredient_id": "HBIN002634","Ingredient_name": "1-hydroxy-3-methoxy-2-methylanthraquinone","Alias": "NA","Ingredient_formula": "C16H12O4","Ingredient_Smile": "CC1=C(C2=C(C=C1)C(=O)C3=C(C2=O)C=CC(=C3)O)OC","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "10413","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

1-hydroxy-5-methoxy-2-methylanthraquinone

NA

C16H12O4 (268.0736)


{"Ingredient_id": "HBIN002639","Ingredient_name": "1-hydroxy-5-methoxy-2-methylanthraquinone","Alias": "NA","Ingredient_formula": "C16H12O4","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "10414","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

7-hydroxy-3-(4-hydroxybenzylidene)-4-chromanone

NA

C16H12O4 (268.0736)


{"Ingredient_id": "HBIN013223","Ingredient_name": "7-hydroxy-3-(4-hydroxybenzylidene)-4-chromanone","Alias": "NA","Ingredient_formula": "C16H12O4","Ingredient_Smile": "C1C(=CC2=CC=C(C=C2)O)C(=O)C3=C(O1)C=C(C=C3)O","Ingredient_weight": "268.26","OB_score": "NA","CAS_id": "110064-50-1","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "7454","PubChem_id": "44443280","DrugBank_id": "NA"}

   

3,4,8,9-tetrahydro-2,7-dioxatetraphene-1,6-dione

3,4,8,9-tetrahydro-2,7-dioxatetraphene-1,6-dione

C16H12O4 (268.0736)


   

2-ethoxy-1-hydroxyanthracene-9,10-dione

2-ethoxy-1-hydroxyanthracene-9,10-dione

C16H12O4 (268.0736)


   

16,16-dimethyl-3,8,17-trioxatetracyclo[11.4.0.0²,⁶.0⁷,¹²]heptadeca-1(13),2(6),4,7(12),10,14-hexaen-9-one

16,16-dimethyl-3,8,17-trioxatetracyclo[11.4.0.0²,⁶.0⁷,¹²]heptadeca-1(13),2(6),4,7(12),10,14-hexaen-9-one

C16H12O4 (268.0736)


   

5-hydroxy-2-(3-methoxyphenyl)chromen-4-one

5-hydroxy-2-(3-methoxyphenyl)chromen-4-one

C16H12O4 (268.0736)


   

4-hydroxy-11-oxatetracyclo[8.7.0.0³,⁸.0¹²,¹⁶]heptadeca-1(10),3,5,7,16-pentaene-2,9-dione

4-hydroxy-11-oxatetracyclo[8.7.0.0³,⁸.0¹²,¹⁶]heptadeca-1(10),3,5,7,16-pentaene-2,9-dione

C16H12O4 (268.0736)


   

1-hydroxy-7-methoxy-2-methylanthracene-9,10-dione

1-hydroxy-7-methoxy-2-methylanthracene-9,10-dione

C16H12O4 (268.0736)


   

6-hydroxy-2-(4-methoxyphenyl)chromen-4-one

6-hydroxy-2-(4-methoxyphenyl)chromen-4-one

C16H12O4 (268.0736)


   

3-hydroxy-8-methoxy-1-methylanthracene-9,10-dione

3-hydroxy-8-methoxy-1-methylanthracene-9,10-dione

C16H12O4 (268.0736)


   

5-methoxy-8,17-dioxatetracyclo[8.7.0.0²,⁷.0¹¹,¹⁶]heptadeca-1(10),2,4,6,11,13,15-heptaen-14-ol

5-methoxy-8,17-dioxatetracyclo[8.7.0.0²,⁷.0¹¹,¹⁶]heptadeca-1(10),2,4,6,11,13,15-heptaen-14-ol

C16H12O4 (268.0736)


   

methyl 3-[3-formyl-5-(hydroxymethyl)-4-methoxy-6-oxopyran-2-yl]prop-2-enoate

methyl 3-[3-formyl-5-(hydroxymethyl)-4-methoxy-6-oxopyran-2-yl]prop-2-enoate

C12H12O7 (268.0583)


   

7-hydroxy-3-(4-hydroxyphenyl)-8-methylchromen-4-one

7-hydroxy-3-(4-hydroxyphenyl)-8-methylchromen-4-one

C16H12O4 (268.0736)


   

1-hydroxy-6-methoxy-3-methylanthracene-9,10-dione

1-hydroxy-6-methoxy-3-methylanthracene-9,10-dione

C16H12O4 (268.0736)


   

7-hydroxy-3-[(4-hydroxyphenyl)methyl]chromen-4-one

7-hydroxy-3-[(4-hydroxyphenyl)methyl]chromen-4-one

C16H12O4 (268.0736)


   

1-hydroxy-2-methoxy-6-methylanthracene-9,10-dione

1-hydroxy-2-methoxy-6-methylanthracene-9,10-dione

C16H12O4 (268.0736)


   

6,8-dihydroxy-2-(4-hydroxyphenyl)-4h-naphthalen-1-one

6,8-dihydroxy-2-(4-hydroxyphenyl)-4h-naphthalen-1-one

C16H12O4 (268.0736)


   

1-hydroxy-7-methoxy-3-methylanthracene-9,10-dione

1-hydroxy-7-methoxy-3-methylanthracene-9,10-dione

C16H12O4 (268.0736)


   

methyl 4-formyl-2-(hydroxymethyl)-5-[(1e)-3-methoxy-3-oxoprop-1-en-1-yl]furan-3-carboxylate

methyl 4-formyl-2-(hydroxymethyl)-5-[(1e)-3-methoxy-3-oxoprop-1-en-1-yl]furan-3-carboxylate

C12H12O7 (268.0583)


   

11-methoxy-9h-phenanthro[2,3-d][1,3]dioxol-3-ol

11-methoxy-9h-phenanthro[2,3-d][1,3]dioxol-3-ol

C16H12O4 (268.0736)


   

5-hydroxy-2-(4-hydroxyphenyl)-7-methylchromen-4-one

5-hydroxy-2-(4-hydroxyphenyl)-7-methylchromen-4-one

C16H12O4 (268.0736)


   

(2s)-4-[(1e)-2-[(carboxymethyl)amino]ethenyl]-2,3-dihydropyridine-2,6-dicarboxylic acid

(2s)-4-[(1e)-2-[(carboxymethyl)amino]ethenyl]-2,3-dihydropyridine-2,6-dicarboxylic acid

C11H12N2O6 (268.0695)


   

1,8-dihydroxy-3,6-dimethylanthracene-9,10-dione

1,8-dihydroxy-3,6-dimethylanthracene-9,10-dione

C16H12O4 (268.0736)


   

methyl (2e)-3-[3-formyl-5-(hydroxymethyl)-4-methoxy-6-oxopyran-2-yl]prop-2-enoate

methyl (2e)-3-[3-formyl-5-(hydroxymethyl)-4-methoxy-6-oxopyran-2-yl]prop-2-enoate

C12H12O7 (268.0583)


   

n-{2-[(2-{[hydroxy(methoxy)methylidene]amino}ethyl)disulfanyl]ethyl}methoxycarboximidic acid

n-{2-[(2-{[hydroxy(methoxy)methylidene]amino}ethyl)disulfanyl]ethyl}methoxycarboximidic acid

C8H16N2O4S2 (268.0551)


   

7-hydroxy-4-(4-methoxyphenyl)chromen-2-one

7-hydroxy-4-(4-methoxyphenyl)chromen-2-one

C16H12O4 (268.0736)


   

5,6-dihydroxy-3-(hydroxymethyl)-2-oxocyclohex-3-en-1-yl furan-2-carboxylate

5,6-dihydroxy-3-(hydroxymethyl)-2-oxocyclohex-3-en-1-yl furan-2-carboxylate

C12H12O7 (268.0583)


   

(2s,4z)-4-{2-[(carboxymethyl)imino]ethylidene}-2,3-dihydro-1h-pyridine-2,6-dicarboxylic acid

(2s,4z)-4-{2-[(carboxymethyl)imino]ethylidene}-2,3-dihydro-1h-pyridine-2,6-dicarboxylic acid

C11H12N2O6 (268.0695)


   

8-hydroxy-3-methoxy-1-methylanthracene-9,10-dione

8-hydroxy-3-methoxy-1-methylanthracene-9,10-dione

C16H12O4 (268.0736)


   

1-hydroxy-3-methoxy-2-methylanthracene-9,10-dione

1-hydroxy-3-methoxy-2-methylanthracene-9,10-dione

C16H12O4 (268.0736)


   

5,7-dihydroxy-8-methyl-2-phenylchromen-4-one

5,7-dihydroxy-8-methyl-2-phenylchromen-4-one

C16H12O4 (268.0736)


   

7-hydroxy-3-[(4-hydroxyphenyl)methylidene]-2h-1-benzopyran-4-one

7-hydroxy-3-[(4-hydroxyphenyl)methylidene]-2h-1-benzopyran-4-one

C16H12O4 (268.0736)


   

1-hydroxy-5-methoxy-3-methylanthracene-9,10-dione

1-hydroxy-5-methoxy-3-methylanthracene-9,10-dione

C16H12O4 (268.0736)


   

3-hydroxy-2-(4-methoxyphenyl)chromen-4-one

3-hydroxy-2-(4-methoxyphenyl)chromen-4-one

C16H12O4 (268.0736)


   

(1s)-14-methoxy-8,17-dioxatetracyclo[8.7.0.0²,⁷.0¹¹,¹⁶]heptadeca-2,4,6,9,11,13,15-heptaen-5-ol

(1s)-14-methoxy-8,17-dioxatetracyclo[8.7.0.0²,⁷.0¹¹,¹⁶]heptadeca-2,4,6,9,11,13,15-heptaen-5-ol

C16H12O4 (268.0736)


   

3-hydroxy-2-methoxy-6-methylanthracene-9,10-dione

3-hydroxy-2-methoxy-6-methylanthracene-9,10-dione

C16H12O4 (268.0736)


   

6-hydroxy-1-methoxy-2-methylanthracene-9,10-dione

6-hydroxy-1-methoxy-2-methylanthracene-9,10-dione

C16H12O4 (268.0736)


   

6-hydroxy-13-methoxy-2-oxatetracyclo[6.6.2.0⁴,¹⁶.0¹¹,¹⁵]hexadeca-1(15),4(16),5,7,11,13-hexaen-3-one

6-hydroxy-13-methoxy-2-oxatetracyclo[6.6.2.0⁴,¹⁶.0¹¹,¹⁵]hexadeca-1(15),4(16),5,7,11,13-hexaen-3-one

C16H12O4 (268.0736)


   

3-hydroxy-7-methoxy-2-phenylchromen-4-one

3-hydroxy-7-methoxy-2-phenylchromen-4-one

C16H12O4 (268.0736)


   

7-hydroxy-8-methoxy-6-methylanthracene-1,2-dione

7-hydroxy-8-methoxy-6-methylanthracene-1,2-dione

C16H12O4 (268.0736)


   

(1s,5r,6r)-5,6-dihydroxy-3-(hydroxymethyl)-2-oxocyclohex-3-en-1-yl furan-2-carboxylate

(1s,5r,6r)-5,6-dihydroxy-3-(hydroxymethyl)-2-oxocyclohex-3-en-1-yl furan-2-carboxylate

C12H12O7 (268.0583)


   

5-hydroxy-7-methoxy-3-phenylchromen-4-one

5-hydroxy-7-methoxy-3-phenylchromen-4-one

C16H12O4 (268.0736)


   

2-(4-hydroxyphenyl)-5-methoxychromen-4-one

2-(4-hydroxyphenyl)-5-methoxychromen-4-one

C16H12O4 (268.0736)


   

6-hydroxy-7-methoxy-3-phenylchromen-2-one

6-hydroxy-7-methoxy-3-phenylchromen-2-one

C16H12O4 (268.0736)